David Loasby
- SEC CIK
- 0001775863
- Latest filing
- Feb 13, 2026
AUPH holding history
Aurinia Pharmaceuticals Inc. in every 13F filed by David Loasby, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AUPH overviewAll 13F holders of AUPHFull Q4 2025 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −19,750−100.0% | Sold out | Holders |
| Q4 2023 | 19,750 | $165.9K | <0.1% | −800−3.9% | Reduced | Holders |
| Q3 2023 | 20,550 | $147.8K | <0.1% | −400−1.9% | Reduced | Holders |
| Q2 2023 | 20,950 | $212.0K | <0.1% | +1,964+10.3% | Added | Holders |
| Q1 2023 | 18,986 | $187.2K | <0.1% | +689+3.8% | Added | Holders |
| Q4 2022 | 18,297 | $152.4K | <0.1% | +18,297 | New | Holders |